These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Hypercalcemic crises in patients with chronic kidney failure due to calcium-containing ion-exchangers, antacids and other drugs]. Graben N; Cremer W; Anlauf M; Bock KD Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1505-8. PubMed ID: 1030032 [No Abstract] [Full Text] [Related]
8. [Hypercalcaemic crises in patients with chronic renal failure caused by ion-exchange resins, antacidotics and other calcium-containing drugs (author's transl)]. Graben N; Cremer W; Anlauf M; Bock KD Dtsch Med Wochenschr; 1977 Dec; 102(52):1903-7. PubMed ID: 598299 [TBL] [Abstract][Full Text] [Related]
9. Resin treatment of hyperkalemia. II. Clinical experience with a cation exchange resin (calcium cycle). Frohnert PP; Johnson WJ; Mueller GJ; Tauxe WN; McCall JT J Lab Clin Med; 1968 May; 71(5):840-6. PubMed ID: 5647685 [No Abstract] [Full Text] [Related]
10. [Experience with ion exhcange resins in the calcium phase during the management of hyperkalemia]. Ritz E; Fanz HE; Herzfeld G Dtsch Med Wochenschr; 1969 Jan; 94(2):75-7. PubMed ID: 5782694 [No Abstract] [Full Text] [Related]
17. Sodium polystyrene sulfonate resin candy for control of potassium in chronic dialysis patients. Johnson K; Cazee C; Gutch C; Ogden D Clin Nephrol; 1976 Jun; 5(6):266-8. PubMed ID: 1277599 [TBL] [Abstract][Full Text] [Related]
18. How should dialysis fluid be individualized for the chronic hemodialysis patient? Potassium. Rachoin JS; Weisberg LS Semin Dial; 2008; 21(3):223-5. PubMed ID: 18363596 [No Abstract] [Full Text] [Related]
19. Dangers of resonium A in the treatment of hyperkalemia in renal failure. Berlyne GM; Janabi K; Shaw AB Lancet; 1966 Jan; 1(7430):167-9. PubMed ID: 4164887 [No Abstract] [Full Text] [Related]